Hillhouse Capital Invested Heavily in Chinese Stocks in Q3 2021
The SEC disclosed Hillhouse Capital's secondary market exposure on November 16.
According to the disclosure from the SEC on November 16, Hillhouse Capital Advisors, Ltd. (HHLR) invested most of its capital in the Chinese concept stocks, biotech companies and other innovative technologies. Their long-term investment strategy hasn't changed much since Q2. Meanwhile, it reportedly closed positions in some US-based stocks and took heavier long positions in Hong Kong-listed equities.
The top three bets of HHLR are currently pharmaceutical companies. Quite a few well-performing TMT firms in China are also in the company's portfolio.
Selected reportsMore
Healthcare, Consumer Staples, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
EqualOcean Analysis
Read next
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.